Company / Capital Expenditures
Embecta Corp. Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$9.3M
FY2025
5-year range
$9.3M / $41.9M
FY2021-FY2025
Trend
-41.1%
vs FY2024
Sector context
#115 of 151
Health Care
What the data says
Embecta Corp.'s capital expenditures of $9M is lower than 76% of companies in the Health Care sector (FY2025). Capital Expenditures has declined for 3 consecutive years, from $42M in FY2022 to $9M in FY2025.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of -26.0%.
Declined from $27M to $9M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -39.5%
- 5-Year CAGR
- -26.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 151This company $9.3M Sector average $271.7M
▼
-96.6% below sector average
Key checks
Key Insights
- Embecta Corp.'s capital expenditures has declined for 3 consecutive years.
- 5-year CAGR of -26.0%, indicating a declining trend.
- In FY2025, capital expenditures decreased 41.1% year-over-year.
- Ranks #115 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.3M | -41.1% |
| FY2024 | $15.8M | -40.4% |
| FY2023 | $26.5M | -36.8% |
| FY2022 | $41.9M | +13.9% |
| FY2021 | $36.8M | -12.2% |
| FY2020 | $41.9M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026